PET Imaging Studies in Drug Abuse

References

• Chapman S. Tobacco control. BMJ 1996; 313: 97–100
   PubMed Web of Science ®Google Scholar
• O'Brien C, McLellan AT. Myths about the treatment of addiction. Lancet 1996; 347: 237–240
   PubMed Web of Science ®Google Scholar
• Leshner AI. Addiction is a brain disease, and it matters. Science 1997; 278: 45–47
   PubMed Web of Science ®Google Scholar
• Mullani N A, Volkow ND. Positron emission tomography instrumentation: A review and update. Am J Physiol Imaging 1992; 7: 121–135
   PubMedGoogle Scholar
• Fowler J S, Wolf AP. Working against time: Rapid radiotracer synthesis and imaging the human brain. Accts Chem Res 1997; 30: 181–188
   Web of Science ®Google Scholar
• Phelps M E, Mazziotta J C, Schelbert H. Positron Computed Tomography. Raven Press, New York 1986
   Google Scholar
• Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274–5278
   PubMed Web of Science ®Google Scholar
• Volkow N D, Fowler J S, Gatley S J. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37: 1242–1256
   PubMed Web of Science ®Google Scholar
• Fowler J S, Volkow N D, Wolf A P. Mapping cocaine binding in human and baboon brain. in vivo. Synapse 1989; 4: 371–377
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Fischman M. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997; 386: 827–830
   PubMed Web of Science ®Google Scholar
• Volkow N D, Fowler J S, Wolf A P. Distribution of 11C-cocaine in human heart, lungs, liver and adrenals. A dynamic PET study. J Nucl Med 1992; 33: 521–525
   PubMedGoogle Scholar
• Ritz M C, Lamb R J, Goldberg S R, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219–1223
   PubMed Web of Science ®Google Scholar
• Fox B S, Kantak K M, Edwards M A. Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 1996; 2: 1129–1132
   PubMed Web of Science ®Google Scholar
• Landry D W, Zhao K, Yang G X, Glickman T M, Georgiadis TM. Antibody-catalyzed degradation of cocaine. Science 1993; 259: 1899–1901
   PubMed Web of Science ®Google Scholar
• Ding Y-S., Sugano Y, Fowler J S, Salata C. Synthesis of the racemate and individual enantiomers of [11C]-methylphenidate for studying presynaptic dopaminergic neurons with positron emission tomography. J Label Cmpds Radiopharm 1994; 34: 989–997
   Web of Science ®Google Scholar
• Volkow N D, Ding Y-S, Fowler J S. Is methyl-phenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 1995; 52: 456–463
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Fowler J S. Relationship between psychostimulant-induced “high” and dopamine transporter occupancy. Proc Natl Acad Sci USA 1996; 93: 10388–10392
   PubMed Web of Science ®Google Scholar
• Gatley S J, Volkow N D, Gifford A N, Ding Y-S, Logan J, Wang G-J. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeledcocaine. Biochem Pharmacol 1997; 53: 43–52
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Fowler J S. Imaging endogenous dopamine competition with [11C]raclo-pride in the human brain. Synapse 1994; 16: 255–262
   PubMed Web of Science ®Google Scholar
• Schlaeper T E, Perlson G D, Wong D F, Dannals RF. PET studies of the competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997; 154: 1209–1213
   PubMed Web of Science ®Google Scholar
• Volkow N D, Mullani N, Gould K L, Adler S, Krajewski K. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br J Psychiatry 1988; 152: 641–648
   PubMed Web of Science ®Google Scholar
• Boag F, Havard C WH. Cardiac arrhythmia and myocardial ischaemia related to cocaine and alcohol consumption. Postgrad Med J 1985; 61: 997–999
   PubMed Web of Science ®Google Scholar
• Hearn W L, Flynn D D, Hime G W. Coca-ethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 1991; 56: 698–701
   PubMed Web of Science ®Google Scholar
• Fowler J S, Volkow N D, MacGregor R R. Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain. Synapse 1992; 12: 220–227
   PubMed Web of Science ®Google Scholar
• Fowler J S, Volkow N D, Logan J, MacGregor R R, Wang G-J, Wolf AP. Alcohol intoxication does not change [C]cocaine pharmacokinetics in human brain and heart. Synapse 1992; 12: 228–235
   PubMed Web of Science ®Google Scholar
• Fowler J S, Ding Y S, Volkow N. PET studies of cocaine inhibition of the myocardial norepinephrine uptake. Synapse 1994; 16: 312–317
   PubMed Web of Science ®Google Scholar
• Melon P G, DeGrado T R, Nguyen N. Noninvasive assessment of regional myocardial sympathetic neuronal function following intravenous cocaine injection in dogs. J Nucl Med 1992; 33: 994
   Google Scholar
• Kloner R A, Hale S, Alker K, Rezkalla A. The effects of acute and chronic cocaine use on the heart. Circulation 1992; 85: 407–419
   PubMed Web of Science ®Google Scholar
• Schwartz W J, Smith C B, Davidsen L. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of rat. Science 1979; 205: 723–725
   PubMed Web of Science ®Google Scholar
• London E D, Broussolle E PM, Links J M. Morphine-induced metabolic changes in human brain: Studies with positron emission tomography and [fluorine-18] fluorodeoxyglucose. Arch Gen Psychiatry 1990; 47: 73–81
   PubMed Web of Science ®Google Scholar
• London E D, Morgan MJ. Positron emission tomographic studies on the acute effects of psychoactive drugs on brain metabolism and mood. Imaging Drug Action in the Brain, London. CRC Press, Boca Raton 1993; 265–280
   Google Scholar
• London E D, Cascella N G, Wong D F. Cocaine induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch General Psychiatry 1990; 47: 567–574
   PubMed Web of Science ®Google Scholar
• Grant S, London E D, Newlin D B. Activation of memory circuits during cue elicited cocaine craving. Proc Natl Acad Sci USA 1996; 93: 12040–12045
   PubMed Web of Science ®Google Scholar
• Childress A R, Mozley D, Fitzgerald J, Reivich M, Jaggi J, O'Brien CP. Limbic activation during cue-induced cocaine craving. Abstracts Society for Neurosciences 1995; 767: 1
   Google Scholar
• Stapleton J M, Henningfield J E, Wong D F. Nicotine reduces cerebral glucose utilization in humans. NIDA Research Monograph. DHHS, Washington, DC 1993; 132: 106
   Google Scholar
• Mapping the cerebral metabolic responses to nicotine. Brain Imaging of Nicotine and Tobacco Smoking, Domini London, EF. NPP Books, Ann Arbor, MI 1995; 153–167
   Google Scholar
• Volkow N D, Fowler J S, Wolf A P. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148: 621–626
   PubMed Web of Science ®Google Scholar
• Volkow N D, Hitzemann R, Wang G-J. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11: 184–190
   PubMed Web of Science ®Google Scholar
• Volkow N D, Fowler J S, Wolf A P. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990; 147: 719–724
   PubMed Web of Science ®Google Scholar
• Volkow N D, Fowler J S, Wang G-J. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169–177
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Fowler J S. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830–833
   PubMed Web of Science ®Google Scholar
• Dackis C A, Gold MS. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev 1985; 9: 469–477
   PubMed Web of Science ®Google Scholar
• Sachs H, Russell J AG, Christman D R, Cook B. Alteration of regional cerebral glucose metabolic rate in non-Korsakoff chronic alcoholism. Arch Neurol 1987; 44: 1242–1251
   PubMed Web of Science ®Google Scholar
• Wik G, Borg S, Sjogren I. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using nC-glu-cose. Acta Psychiatr Scand 1988; 78: 234–241
   PubMed Web of Science ®Google Scholar
• Samson Y, Baron J C, Feline A, Bories J, Crouzel C. Local cerebral glucose utilization in chronic alcoholics: A positron tomographic study. J Neurol Neurosurg Psychiatry 1986; 49: 1165–1170
   PubMed Web of Science ®Google Scholar
• Kessler R M, Parker E S, Clark CM. Regional cerebral glucose metabolism in patients with alcoholic Korsakoff's syndrome. Soc Neurosci (Abstract) 1984; 10: 541
   Google Scholar
• Volkow N D, Hitzemann R, Wang G-J. Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry 1992; 149: 1016–1022
   PubMed Web of Science ®Google Scholar
• Mathew R J, Wilson WH. Substance abuse and cerebral blood flow. Am J Psychiatry 1991; 148: 292–305
   PubMed Web of Science ®Google Scholar
• Lotfi J, Meyer JS. Cerebral hemodynamic and metabolic effects of chronic alcoholism. Cerebrovas Brain Metab Rev 1989; 1: 2–25
   PubMedGoogle Scholar
• Volkow N D, Wang G-J, Hitzemann R. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 1994; 151: 178–183
   PubMed Web of Science ®Google Scholar
• De Wit H, Metz J, Wagner N, Cooper M. Behavioral and subjective effects of ethanol: Relationship to cerebral metabolism using PET. Alcohol Clin Exp Res 1990; 14: 482–489
   PubMed Web of Science ®Google Scholar
• Volkow N D, Hitzemann R, Wolf A P. Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Res 1990; 35: 39–48
   PubMed Web of Science ®Google Scholar
• Volkow N D, Guynn R, Marani S, Adler S, Gould L. Effects of alcohol on cerebral blood flow. Psychiatry Res 1988; 24: 201–209
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Hitzemann R. Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry 1993; 150: 417–422
   PubMed Web of Science ®Google Scholar
• Volkow N D, Wang G-J, Begleiter H. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Gin Exp Res 1995; 19: 510–516
   Web of Science ®Google Scholar
• Litton J E, Neiman J, Pauli S. PET anlaysis of [11CJflumazenil binding to benzodiazepinereceptorsin chronic alcohol-dependent men and healthy controls. Psychiatry Res 1993; 50: 1–13
   PubMedGoogle Scholar
• Volkow N D, Wang G-J, Fowler J S. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594–1598
   PubMed Web of Science ®Google Scholar
• Hietala J, West C, Syvalahti E. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 1994; 116: 285–290
   PubMed Web of Science ®Google Scholar
• Goodman L S, Gilman A. The Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, New York 1990; 549
   Google Scholar
• Herkenham M, Lynn A B, Little M D. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932
   PubMed Web of Science ®Google Scholar
• Mathew R J, Wilson W H, Tant SR. Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatry Scand 1989; 79: 118
   PubMed Web of Science ®Google Scholar
• Tunuing K, Thulin S D, Risberg J. Regional cerebral blood flow in long term heavy cannabis use. Psychiatry Res 1986; 17: 15
   PubMed Web of Science ®Google Scholar
• Nahas GG. Toxicolology and Pharmacology. Marijuana in Science and Medicine, GG Nahas. Raven Press, New York 1986; 109
   Google Scholar
• Sokoloff L, Reivich M, Kennedy C. The 11C-deoxyglucose method for the measurement of local cerebral glucose utilization: The conscious and anesthetized albino rat. J Neurochem 1977; 28: 897
   PubMed Web of Science ®Google Scholar
• Volkow N D, Gillespie H, Mullani N. Cerebellar metabolic activation by Delta-9-tetrahydrocannabinol in human brain: A study with Positron Emission Tomography and F-2-Fluoro-deoxyglucose. Psychiatry Res 1991; 40: 69–78
   PubMed Web of Science ®Google Scholar
• Volkow N D, Gillespie H, Mullani N. Brain glucose metabolism in chronic marijuana users during baseline and during marijuana intoxication. Psychiatry Res 1996; 67: 29–38
   PubMed Web of Science ®Google Scholar
• Charalembous A, Marciniak G, Shive C-Y. PET studies in the primate brain and biodistribution in mice using (-)-5′-18F-delta 8-THC. Pharmacol Biochem Behavior 1991; 40: 503–507
   PubMed Web of Science ®Google Scholar
• Gatley SJ, Gifford A, Makriyannis A, Volkow ND. Iodine-123 labeled AM 251: A radioiodinated ligand with binding in vivo to mouse brain CB1 cannabinoid receptors. Eur J Pharmacol 1996; 307: 301–308
   Google Scholar
• Gatley S J, Lan R, Volkow N D. Imaging the brtain marijuana receptor: development of a radioligand that binds to cannabinoidCB1 recrptorsin. vivo. JNeurochem 1998; 70: 417–423
   PubMed Web of Science ®Google Scholar
• Oreland L, Fowler C J, Schalling D. Low platelet monoamine oxidase activity in cigarette smokers. Life Sci 1981; 29: 2511–2518
   PubMed Web of Science ®Google Scholar
• Norman T R, Chamberlain K G, French MA. Platelet monoamine oxidase: Low activity in cigarette smokers. Psychiatry Res 1987; 20: 199–205
   PubMed Web of Science ®Google Scholar
• Fowler J S, Volkow N D, Wang G-J. Inhibition of MAO B in the brains of smokers. Nature 1996; 379: 733–736
   PubMed Web of Science ®Google Scholar
• Fowler JS, Volkow N D, Wang G-J. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 1996; 93: 14065–14069
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1985; 9: 526–533
   Google Scholar
• Morens D M, Grandinetti A, Reed D, White L R, Ross GW. Cigarette smoking and protection from Parkinson's disease: False association or etiological clue. Neurology 1995; 45: 1041–1051
   PubMed Web of Science ®Google Scholar
• Glassman A H, Helzer J E, Covey L S. Smoking, smoking cessation and major depression. JAMA 1990; 264: 1546–1549
   PubMed Web of Science ®Google Scholar
• Henningfield J E, Clayton R, Pollin W. Involvement of tobacco in alcoholism and illicit drug use. Br J Addiction 1990; 85: 279–292
   PubMedGoogle Scholar